FOSL2 | FOS-like antigen 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
GALNT7 | Polypeptide N-acetylgalactosaminyltransferase 7 | Predicted intracellular proteins
| | | | | Mixed |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GNS | Glucosamine (N-acetyl)-6-sulfatase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GOLGA4 | Golgin A4 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPHN | Gephyrin | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HLA-E | Major histocompatibility complex, class I, E | Predicted membrane proteins
| | | | | Expressed in all |
HN1L | Hematological and neurological expressed 1-like | Predicted intracellular proteins
| | | | | Expressed in all |
HOOK2 | Hook microtubule-tethering protein 2 | Predicted intracellular proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IER3IP1 | Immediate early response 3 interacting protein 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
IRF2 | Interferon regulatory factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ISOC2 | Isochorismatase domain containing 2 | Predicted intracellular proteins
| | | | | Expressed in all |
IST1 | Increased sodium tolerance 1 homolog (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ISYNA1 | Inositol-3-phosphate synthase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IVD | Isovaleryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LMAN1 | Lectin, mannose-binding, 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MAN1A2 | Mannosidase, alpha, class 1A, member 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MANEA | Mannosidase, endo-alpha | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MAP1B | Microtubule-associated protein 1B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MAPKAP1 | Mitogen-activated protein kinase associated protein 1 | Predicted intracellular proteins
| | | | | Expressed in all |
MAVS | Mitochondrial antiviral signaling protein | Predicted membrane proteins
| | | | | Expressed in all |